Post-transplant Hepatitis C

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00811RibavirinNot AvailableApproved for Marketing1
DB08934SofosbuvirNot AvailableApproved for Marketing1